Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extensionResearch in context by Smeeta Sinha, Sagar U. Nigwekar, Vincent Brandenburg, Lisa J. Gould, Thomas E. Serena, Sharon M. Moe, George R. Aronoff, Dinesh K. Chatoth, Jeffrey L. Hymes, Kevin J. Carroll, Gabriela Alperovich, Laurence H. Keller, Joan Perelló, Alex Gold, Glenn M. Chertow

Get full text